17089-349 NDC - GUNA-GERIATRICS (1,4-BENZOQUINONE - ARNICA MONTANA - OXYTOCIN - BARIUM CARBONATE - BARIUM OXALOSUCCINATE - CORTICOTROPIN - LEAD - LEVOTHYROXINE - LUTRELIN - MALIC ACID - MELATONIN - NEUROTROPHIN-3 - NEUROTROPHIN-4 - PHENYLALANINE - PORK LIVER - PYRUVIC ACID - RINFABATE - SUS SCROFA ADRENAL GLAND - SUS SCROFA FRONTAL LOBE - SUS SCROFA HYPOTHALAMUS - THYROTROPIN ALFA - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN -)

Drug Information

Product NDC: 17089-349

Proprietary Name: GUNA-GERIATRICS

Non Proprietary Name: 1,4-benzoquinone - arnica montana - oxytocin - barium carbonate - barium oxalosuccinate - corticotropin - lead - levothyroxine - lutrelin - malic acid - melatonin - neurotrophin-3 - neurotrophin-4 - phenylalanine - pork liver - pyruvic acid - rinfabate - sus scrofa adrenal gland - sus scrofa frontal lobe - sus scrofa hypothalamus - thyrotropin alfa - brain-derived neurotrophic factor human -

Active Ingredient(s):
  • 6 [hp_X]/30mL ARNICA MONTANA;
  • 6 [hp_X]/30mL BARIUM CARBONATE;
  • 3 [hp_X]/30mL BARIUM OXALOSUCCINATE;
  • 4 [hp_C]/30mL BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN;
  • 6 [hp_X]/30mL CORTICOTROPIN;
  • 6 [hp_X]/30mL LEAD;
  • 6 [hp_X]/30mL LEVOTHYROXINE;
  • 6 [hp_X]/30mL LUTRELIN;
  • 3 [hp_X]/30mL MALIC ACID;
  • 4 [hp_C]/30mL MELATONIN;
  • 4 [hp_C]/30mL NEUROTROPHIN-3;
  • 4 [hp_C]/30mL NEUROTROPHIN-4;
  • 6 [hp_X]/30mL OXYTOCIN;
  • 3 [hp_X]/30mL PHENYLALANINE;
  • 6 [hp_X]/30mL PORK LIVER;
  • 3 [hp_X]/30mL PYRUVIC ACID;
  • 3 [hp_X]/30mL QUINONE;
  • 4 [hp_C]/30mL RINFABATE;
  • 6 [hp_X]/30mL SUS SCROFA ADRENAL GLAND;
  • 6 [hp_X]/30mL SUS SCROFA FRONTAL LOBE;
  • 6 [hp_X]/30mL SUS SCROFA HYPOTHALAMUS;
  • 6 [hp_X]/30mL THYROTROPIN ALFA


Administration Route(s): ORAL

Dosage Form(s): SOLUTION/ DROPS

Pharmacy Class(es):
  • Adrenocorticotropic Hormone [CS];
  • Adrenocorticotropic Hormone [EPC];
  • Increased Uterine Smooth Muscle Contraction or Tone [PE];
  • Oxytocic [EPC];
  • Oxytocin [CS];
  • Thyroid Stimulating Hormone [EPC];
  • Thyrotropin [CS];
  • Thyroxine [CS];
  • l-Thyroxine [EPC]

Labeler Information

Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/16/2008

Package Information

No. Package Code Package Description Billing Unit
117089-349-181 BOTTLE, DROPPER in 1 BOX (17089-349-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-349The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGUNA-GERIATRICSThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME1,4-benzoquinone - arnica montana - oxytocin - barium carbonate - barium oxalosuccinate - corticotropin - lead - levothyroxine - lutrelin - malic acid - melatonin - neurotrophin-3 - neurotrophin-4 - phenylalanine - pork liver - pyruvic acid - rinfabate - sus scrofa adrenal gland - sus scrofa frontal lobe - sus scrofa hypothalamus - thyrotropin alfa - brain-derived neurotrophic factor human -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/16/2008This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEARNICA MONTANA; BARIUM CARBONATE; BARIUM OXALOSUCCINATE; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; CORTICOTROPIN; LEAD; LEVOTHYROXINE; LUTRELIN; MALIC ACID; MELATONIN; NEUROTROPHIN-3; NEUROTROPHIN-4; OXYTOCIN; PHENYLALANINE; PORK LIVER; PYRUVIC ACID; QUINONE; RINFABATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA FRONTAL LOBE; SUS SCROFA HYPOTHALAMUS; THYROTROPIN ALFAAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 3; 4; 6; 6; 6; 6; 3; 4; 4; 4; 6; 3; 6; 3; 3; 4; 6; 6; 6; 6 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESAdrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS], Thyroid Stimulating Hormone [EPC], Thyrotropin [CS], Thyroxine [CS], l-Thyroxine [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023